Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TLE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZNF746 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RASSF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHDDS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C6orf89 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP4V2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDZD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFNAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRIMPOL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF149 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATG4C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDGA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALG6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on